California Federal Judge Signals Likely Class Certification in Juul–Altria Antitrust Case

Oct.20.2025
California Federal Judge Signals Likely Class Certification in Juul–Altria Antitrust Case
U.S. District Judge William Orrick of the Northern District of California indicated on Friday that he will likely certify classes of direct and indirect purchasers accusing e-cigarette makers Juul Labs Inc. and former rival Altria Group Inc. of conspiring to limit product variety and violate antitrust laws.

Key points

 

  • A federal judge in California is set to approve class-action certification in the antitrust lawsuit between Juul and Altria. 
  • Altria's attorneys have warned that differences in state laws could lead to "Frankenstein-like" damages. 
  • The plaintiffs argue that California is at the center of the alleged conspiracy by Juul, so California law should apply. 
  • The case involves consumers and distributors in 31 states and may proceed with compensation in phases. 
  • The lawsuit stems from Altria's $12.8 billion investment in Juul in 2018. In the United States, class-action lawsuits must undergo court review and approval to proceed.

 


2Firsts, October 17, 2025 — U.S. District Judge William Orrick signaled that he is likely to certify classes of direct and indirect purchasers in an antitrust case accusing Juul Labs and Altria Group of colluding to restrict competition and reduce product variety.

 

During a Zoom hearing, Judge Orrick confirmed he had issued a tentative written ruling but would finalize his decision later in writing. Altria’s attorney James Rosenthal argued that conflicting state laws among 31 jurisdictions would make any damages framework unworkable and warned against creating a “Frankenstein’s monster” of multi-state damages calculations. He also opposed splitting the trial into separate liability and damages phases, noting it would require defense experts to testify twice.

 

Plaintiffs’ attorney Elana Katcher of Kaplan Fox Kilsheimer responded that minor state law variations should not block class certification, stressing California’s stake as Juul’s headquarters and a major market “during the conspiracy.” She argued that California’s Cartwright Act provides a coherent basis for liability and damages across the classes.

 

The suit was filed in 2020 after Altria’s $12.8 billion investment in Juul was challenged as anticompetitive. Although Altria fully divested its stake in 2023 and the FTC dropped its case, plaintiffs contend the companies could re-enter partnerships in the future.

 

The case is In re Juul Labs Inc. Antitrust Litigation, No. 3:20-cv-02345, before Judge William Orrick in the Northern District of California. A final written order on class certification is pending.

 

Image source: 2Firsts

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Philippine Local Governments Urge Marcos to Prioritize Smoke- and Vape-Free Bill
Philippine Local Governments Urge Marcos to Prioritize Smoke- and Vape-Free Bill
The League of Municipalities of the Philippines (LMP) has urged President Ferdinand Marcos Jr. to prioritize the Smoke- and Vape-Free Bill, seeking a nationwide legal framework for tobacco and vape regulation. Local government leaders said national legislation would help standardize enforcement and strengthen public health measures. The proposal remains at the advocacy stage and has not yet become law.
Jul.29
Senate Democrat Wyden Probes Trump Administration Vape Policy Shift, Seeks Records From HHS and Reynolds American
Senate Democrat Wyden Probes Trump Administration Vape Policy Shift, Seeks Records From HHS and Reynolds American
U.S. Senator Ron Wyden, the Democratic ranking member of the Senate Finance Committee, has launched an investigation into flavored vape policy changes and requested records from the Department of Health and Human Services (HHS), Reynolds American and Botanic Tonics. The investigation focuses on a timeline involving Reynolds American’s $5 million donation to MAGA Inc. in April 2026 and subsequent vape policy developments. Wyden said the review aims to examine potential links between political donations, corporate communications and government decisions. The investigation does not represent a finding of wrongdoing.
Innovation
Aug.07 by 2Firsts Perspectives
Illegal Vape Retailers in UK Could Face 12-Month Shutdowns
Illegal Vape Retailers in UK Could Face 12-Month Shutdowns
The UK government plans to expand police and trading standards powers by extending closure orders for shops selling illegal vapes and cigarettes from a maximum of six months to 12 months, in a crackdown on organised crime on high streets.
Jun.12
FDA Tobacco Proposal Signals Full-Chain Compliance Test for Global E-Cigarette Supply Chains
FDA Tobacco Proposal Signals Full-Chain Compliance Test for Global E-Cigarette Supply Chains
FDA’s proposed foreign tobacco establishment registration and product listing rule remains unfinished, but Accorto told 2Firsts it reflects a shift toward structured oversight similar to medical device and pharmaceutical compliance frameworks. For Chinese and global e-cigarette suppliers, U.S. market access is moving beyond product authorization toward full-chain compliance covering manufacturing, documentation, import control, distribution, retail and marketing discipline.
Special Report
Jul.09
Changing Assumptions in U.S. Cigar Consumption: 2Firsts Interviews Cigar Educator Mechelle Merkerson
Changing Assumptions in U.S. Cigar Consumption: 2Firsts Interviews Cigar Educator Mechelle Merkerson
U.S. premium cigar culture is shifting toward education, broader choice and deeper links to craftsmanship and origin, cigar educator Mechelle Merkerson told 2Firsts. She sees boutique brands, women consumers and production-region experiences making knowledge central to cigar participation. For global brands, retailers and emerging markets such as China, education may help turn curiosity into sustained engagement.
Special Report
Jul.06
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
A new Swedish study found oral mucosal lesions in 79% of examined nicotine pouch users and 89% of tobacco-derived snus users, with different tissue-response patterns between the two categories. For manufacturers and regulators, the findings shift attention toward product formulation, flavouring, pouch materials and local oral exposure, not only whether a product contains tobacco. The study found no higher prevalence of caries or periodontal disease, but it could not establish causality, long-term outcomes or differences between individual products or designs.
Special Report
Jul.27